The pilot by the FDA’s CDRH will improve communications about corrective actions being taken over certain medical device ...
Ins ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has received IND clearance from FDA for ISM5939, a potential best-in-class ...
The FDA's Center for Devices and Radiological Health announced a pilot program designed to improve the timeliness of communications regarding high-risk medical device recalls.
The Digital Health Advisory Committee (DHAC) held its first meeting to offer guidance to the FDA on a slew of questions ...
The bipartisan proposal goes further than the Transitional Coverage for Emerging Technologies (TCET) pathway that CMS is ...
The Center for Devices and Radiological Health’s pilot program is meant to cut the time between the FDA’s awareness of ...
Partner content with ISACA. FDA studies have found that in the medical device industry, compliance alone is not enough to ensure improved quality indicators. Why? Because compliant medical-device ...
Insightec announced today that it received FDA approval and CE mark for its Exablate Prime system with certain Philips MR ...
The U.S. Food and Drug Administration will focus on “Total Product Lifecycle Considerations for Generative AI-Enabled Devices” during its ...
The FDA will discuss a new framework for regulating generative artificial intelligence (GenAI)-enabled medical devices.
In October 2024, Omron Healthcare received de novo authorisation from the US Food and Drugs Administration (FDA) to market ...
Augmedics has received the Food and Drug Administration (FDA) 510(k) clearance of the new CT-to-fluoroscopy (CT-Fluoro) registration method for its xvision spine system. Navigating off using ...